Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net income	$ 861.5	$ 175.7
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	320.0	169.2
Impairment of goodwill, intangibles and other assets	84.6
Net gain from sale of businesses	(758.1)	(161.9)
Loss on extinguishment of debt	(1.9)	47.1
Deferred income taxes	(60.9)	60.1
Stock-based compensation expense	39.7	29.1
Other, net	6.2	11.3
Changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures:
Accounts receivable	(49.4)	(255.8)
Inventories	(498.8)	314.6
Accounts payable	177.2	243.3
Accrued liabilities and other	(361.1)	(296.8)
Net cash provided by (used) in operating activities	(241.0)	335.9
Cash flows from investing activities:
Proceeds from sale of divested businesses	1,901.7	236.4
Acquisitions and acquisition-related activities	(557.6)	(8,597.7)
Capital expenditures	(191.2)	(163.9)
Other investing activities	5.4	6.5
Net cash provided by (used in) investing activities	1,158.3	(8,518.7)
Cash flows from financing activities::
Net short-term debt	620.1	47.2
Proceeds from issuance of debt, net of debt issuance costs		9,414.6
Payments on long-term debt	(1,159.5)	(750.0)
Cash dividends	(204.3)	(145.0)
Equity compensation activity and other, net	(19.8)	(17.9)
Net cash provided by (used in) financing activities	(763.5)	8,548.9
Exchange rate effect on cash and cash equivalents	38.9	(13.6)
Increase in cash and cash equivalents	192.7	352.5
Cash and cash equivalents at beginning of period	587.5	274.8
Cash and cash equivalents at end of period	$ 780.2	627.3
Supplemental non-cash disclosures:
Common stock issued for Jarden Acquisition		9,480.3
Debt assumed, at fair value, in the Jarden Acquisition		$ 1,124.0